Anti-Human HLA-DRB Recombinant Antibody

Product Information

Catalog Number	YR1018
Product Name	Anti-Human HLA-DRB Recombinant Antibody
Molecular Name	Apolizumab
Alias	Anti-HLA-DRB Recombinant Antibody, Research Grade Apolizumab
CAS Number	267227-08-7
Target	HLA-DRB[Homo sapiens]
Isotype	IgG1
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	ELISA, IP, FCM, FuncS, Neut, IF, ICC
Buffer	PBS, pH7.5
Background	Apolizumab is a humanized monoclonal antibody intended for use in hematologic cancers. Development was abandoned in 2005 because of toxic effects and lack of efficacy in human patients. The observed dose limiting toxic effects were aseptic meningitis and hemolytic uremia. There are no current clinical trials into its use.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price